Yes it will be great for actuall low cost producers. As for this stock maybe in 2025-2028. I guess you guys are all happy with the kick the can approach?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%